|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1717 PENNSYLVANIA AVENUE, NW |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 24806-12
|
||||||||
|
6. House ID# 336110000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Anders Gilberg |
Date | 1/5/2021 3:40:10 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues:
Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act
Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration
APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration
ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021
Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress
MIPS: advocated to administration for reductions in reporting burden for 2021
Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package
Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency
Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases
Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program
National Patient Identifier: advocated for the development of a national approach to matching patient records
Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers
Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement
Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations
Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency
Bills:
HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions
HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions
HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze
H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anders |
Gilberg |
|
|
|
Robert |
Tennant |
|
|
|
Mollie |
Gelburd |
|
|
|
Claire |
Ernst |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues:
Telehealth: Advocated for extension of Medicare telehealth waivers under 1834m of the Social Security Act
Surprise medical bills: advocated for independent dispute resolution improvements in No Surprises Act such as exclusion of federal payer rates from consideration
APMs: advocated for freeze in qualifying participant thresholds and extension of APM bonus in Value Act; advocated for delay and improvements to radiation oncology model to administration
ACOs: advocated to administration to delay or rescind proposals for quality reporting changes in 2021
Provider relief fund: advocated for improvements to reporting requirements and for distributions to group practices in front of administration and congress
MIPS: advocated to administration for reductions in reporting burden for 2021
Accelerated advance payment program: advocated to congress to include improved repayment terms in federal legislative package
Medicare sequestration: advocated for a delay in the sequestration cuts through the end of the COVID-19 public health emergency
Medicare payment cuts: advocated against cuts to Medicare reimbursement slated for Jan. 1, 2021 related to the E/M increases
Appropriate Use Criteria (AUC) program: advocated for a delayed start to the program
National Patient Identifier: advocated for the development of a national approach to matching patient records
Medicare Document Requirement Lookup Service policy: advocated in support of real time transactions; applicability to all payers
Medicare administrative simplification policy: advocated for development of new attachment standards; improved prior authorization processes; enhanced enforcement
Application Programming Interface prior authorization standards: advocated for applicability to a wider group of federally-controlled payers; reduced time for payers to respond to practices with authorization determinations
Interoperability and information blocking policy: advocated against additional administrative burden for physician practices; delay in enforcement for information blocking requirements until after the COVID-19 public health emergency
Bills:
HR 8702, Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020, all provisions
HR 8505, To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes, all provisions
HR 133, Consolidated Appropriations Act, 2021, provisions relating to Medicare reimbursement cuts, sequestration cut delay, surprise medical billing, radiation oncology model delay, and APM qualifying participant threshold freeze
H.R.7898 - To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Claire |
Ernst |
|
|
|
Mollie |
Gelburd |
|
|
|
Anders |
Gilberg |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |